UDM-001651

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameUDM-001651
Drug Alias NameUDM-001651
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtease-activated receptor-4 antagonists
TargetsProtease-activated receptor-4
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A